The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (8 analysts) rates it none, with a mean price target of $206.
Broadridge Financial Solutions
BR · a US exchange · USD · Market cap $19.0B · 15,000 employees
Broadridge Financial Solutions, Inc.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Screened 2026-09-21 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 164.62 against the desk's fair-value range, base estimate 225.76, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Broadridge Financial Solutions holds its Distribution at $164.62. The statistical read favours the sellers, held for 24 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 24 days |
| Price at the screen | $164.62 |
| Valuation | 17.17 trailing · 14.22 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.91 |
Five Screens, Shown in Full
Does not pass. Business activity: conventional financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
| Debt load | 40.48% | Below 33% | Interest-bearing debt is 40.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 3.50% | Below 33% | Cash held in interest-bearing accounts and securities is 3.5% of assets, under the one-third limit. | Pass |
| Receivables | 19.18% | Below 49% | Money owed to the company is 19.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.19% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 37% discount to our $225.76 fair value, moderate competitive moat, 7.50% revenue growth.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. A 37.1% margin of safety to the base estimate.
Third-party analyst targets: 8 covering, consensus Buy. The average target sits +34% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBroadridge fails its ethics test on debt
Every proxy vote and fund statement still needs printing and delivery. Broadridge sits in the middle of that flow, posting steady eight percent revenue growth and a forty two percent return on equity. Yet the opportunity rating sits at avoid because the stock fails our ethical screen on its debt ratio, and that single red flag overrides the fourteen point four times forward earnings and moderate moat.
The eight analysts calling it a buy with a two hundred seven dollar median target ignore the leverage that sits on the balance sheet. At current prices the margin of safety looks attractive next to our one hundred eighty six dollar fair value, yet high debt turns what appears a defensive business into something more fragile when rates stay elevated.
Profit margins at fifteen percent show the operation runs well, but the ethical failure on debt is not negotiable. We pass. Analysis, not advice.
| Forward P/E | 14.2xpriced for continued growth |
| Trailing P/E | 17.2xreasonably valued |
| EPS, trailing | 9.59 |
| EPS, forward | 11.58 |
| Revenue growth | +7.5%slow but positive growth |
| Profit margin | 15.0%healthy profit margins |
| Return on equity | 40.9%an exceptional return on shareholder capital |
| FCF yield | 6.23% |
| Dividend yield | 261.00% |
| Debt to equity | 1.24a meaningful debt load worth watching |
| Current ratio | 1.24adequate liquidity, worth monitoring |
| Beta | 0.91steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 133.83 - 255.74 |
| Moat | MODERATE |
| Market cap | $19.0B |
| Employees | 15,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBR trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (8 analysts) rates it none, with a mean price target of $206.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (8 analysts) rates it none, with a mean price target of $206.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is Broadridge Financial Stock Underperforming the S&P 500? Barchart · 6d ago
- BR Stock Rises 16.1% in 3 Months: Here's What You Should Know Zacks · 11d ago
- Q2 Earnings Highs And Lows: Broadridge (NYSE:BR) Vs The Rest Of The Data & Business Process Services Stocks StockStory · 13d ago
- Why Is Broadridge Financial (BR) Up 9% Since Last Earnings Report? Zacks · 19d ago
- Broadridge Financial Solutions (BR) Following Its Repo Expansion Still Looks Undervalued Simply Wall St. · 19d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-08 | MURRAY EILEEN K. | Director | 29 | · | |
| 2026-04-08 | KELLER BRETT A | Director | 80 | · | |
| 2026-04-08 | FLOWERS MELVIN L | Director | 16 | · | |
| 2026-04-08 | ZAVERY AMIT | Director | 51 | · | |
| 2026-04-08 | DUELKS ROBERT N | Director | 127 | · | |
| 2026-04-08 | MARKUS MAURA A | Director | 116 | · | |
| 2026-04-08 | NAZARETH ANNETTE L. | Director | 33 | · | |
| 2026-04-08 | MOSCONI PATRICIA ANN | Director | 2 | · | |
| 2026-04-07 | MURRAY EILEEN K. | Director | 384 | · | |
| 2026-04-07 | KELLER BRETT A | Director | 177 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-26 | David Taylor | Republican | buy | 1K–15K |
| 2026-08-26 | David Taylor | Republican | buy | 1K–15K |
| 2026-08-26 | David Taylor | Republican | buy | 1K–15K |
| 2026-08-26 | David Taylor | Republican | buy | 1K–15K |
| 2026-08-26 | David Taylor | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $149.13 | -2.2% | · | $978 | -2.2% |
| 2 months | $151.12 | -3.5% | · | $965 | -3.5% |
| 3 months | $176.42 | -17.4% | $0.98 | $832 | -16.8% |
| 6 months | $229.26 | -36.4% | $1.95 | $645 | -35.5% |
| 1 year | $238.85 | -39.0% | $3.81 | $626 | -37.4% |
| 2 years | $190.43 | -23.4% | $7.25 | $804 | -19.6% |
| 3 years | $146.32 | -0.3% | $10.37 | $1,067 | +6.7% |
| 5 years | $149.52 | -2.5% | $15.68 | $1,080 | +8.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.